U.S. markets open in 2 hours 17 minutes

  • S&P Futures

    4,653.00
    +10.00 (+0.22%)
     

  • Dow Futures

    35,928.00
    +99.00 (+0.28%)
     

  • Nasdaq Futures

    16,065.00
    +42.25 (+0.26%)
     

  • Russell 2000 Futures

    2,413.90
    +5.80 (+0.24%)
     

  • Crude Oil

    80.03
    -1.56 (-1.91%)
     

  • Gold

    1,852.30
    -11.60 (-0.62%)
     

  • Silver

    25.05
    -0.25 (-0.99%)
     

  • EUR/USD

    1.1451
    -0.0003 (-0.02%)
     

  • 10-Yr Bond

    1.5600
    0.0000 (0.00%)
     

  • Vix

    17.28
    -1.45 (-7.74%)
     

  • GBP/USD

    1.3395
    +0.0028 (+0.21%)
     

  • USD/JPY

    114.0210
    -0.0250 (-0.02%)
     

  • BTC-USD

    63,958.98
    -1,016.14 (-1.56%)
     

  • CMC Crypto 200

    1,580.52
    -17.45 (-1.09%)
     

  • FTSE 100

    7,361.18
    -23.00 (-0.31%)
     

  • Nikkei 225

    29,609.97
    +332.11 (+1.13%)
     

Global Human Microbiome Therapeutics Market 2021-2027: Including Profiles of Bristol-Myers Squibb, Vertex Pharmaceuticals, Puretech Health and Pfizer

Research and Markets
·2 min read

Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "Human Microbiome Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The global human microbiome therapeutics market is expected to grow at a CAGR of around 42.7% during 2021-2027.

This report on global human microbiome therapeutics market report provides a holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global human microbiome therapeutics market by segmenting the market based on technology, therapeutic area, type, and region.

Also, detailed profiles of companies operating in the human microbiome therapeutics market are provided in this report.

Companies Mentioned

  • Bristol-Myers Squibb

  • Dow Inc Chemical

  • Takeda Pharmaceutical Company Limited

  • Johnson & Johnson

  • DuPont de Nemours, Inc.

  • Merck & Co. Inc.

  • Pfizer Inc.

  • Vertex Pharmaceuticals

  • Evelo Biosciences, Inc.

  • Kaleido Biosciences, Inc.

  • Seres Therapeutics, Inc.

  • PureTech Health PLC

Market Drivers

  • Human Microbiome as a Validated Target for Drug Development

  • Increasing Focus on Human Microbiome Therapeutics Development

  • Increasing Collaboration Between Public-Private Organizations

Market Challenges

  • Stringent Government Regulations

  • Lack of Expertise and Adequate Research

Historical & Forecast Period

Base Year: 2020
Historical Period: 2016-2019
Forecast Period: 2021-2027

Market by Technology

  • Genomics

  • Proteomics

  • Metabolomics

Market by Route of Therapeutic Area

  • Neurological Disorders

  • Dermatological Indications

  • Cancers

  • Metabolic Disorders

  • Gastrointestinal Disorders

  • Others

Market by Type

  • Probiotics and Prebiotics

  • Medical Food

  • Diagnostic Tests

  • Others

Market by Region

  • Europe

  • North America

  • Asia Pacific

  • Latin America

  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/thkrue

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Recommended Stories

  • It’s bizarro world in the auto industry, again

    Another electric startup, Rivian, has roared into the market with no sales but a higher valuation than Ford and GM.

  • Suze Orman says this is the only asset class that has a track record of beating inflation — don't give up on it just yet

    Experts are worried about this asset. But Suze still likes it.

  • Biden Faces Pleas for Oil Export Ban That Would Upend Markets

    (Bloomberg) -- President Joe Biden faces growing pressure even from fellow Democrats to address rising gasoline prices with measures such as a ban on oil exports, a move that could upend global markets, discourage shale drilling and end up not helping American drivers that much. Most Read from BloombergWhy Hong Kong Is Building Apartments the Size of Parking SpacesFarmers Take on ‘Post-Apocalyptic’ Food CrisisDo Prisons Deserve a Second Chance?Greece’s Popular Islands Are Crowded — With PlasticI

  • Alibaba’s Singles Day Sales Smashed Records. But Will the Stock Beat History?

    China's version of Black Friday saw Alibaba trump last year's sales, though year-over-year sales growth does appear to be slowing.

  • Traders left on the hook for expensive coal after China squashes prices

    Chinese coal traders are selling cargoes at losses or trying to delay imports after Beijing's market interventions triggered a 50% price drop that saddled them with unprofitable supplies, according to several market participants. Domestic thermal coal futures have halved over the past three weeks after the government ordered top miners to slash prices to a set target and raise output immediately to curb prices that had nearly quadrupled this year. Amid the price free-fall, importers have tried to quickly sell on their coal shipments they booked in October when prices were at records, taking losses of between $40 to $100 per tonne, said three China-based coal traders.

  • J&J plans to split into two public companies and separate consumer and drug businesses

    Johnson & Johnson shares (jnj) jumped 3.6% in premarket trade Friday, after Chief Executive Alex Gorksy told the Wall Street Journal that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. J&J will separate the consumer business in 18 to 24 months, he said, because its customers and markets have diverged so much from the rest of the business in recent years, including during the pandemic. "The best path forward to ensure sustainable growth over the long term and better meet patient and consumer demands is to have our consumer business operate as a separate healthcare company," Mr. Gorsky said in an interview.

  • China's Singles' Day loses lustre as growth slumps to single digit amid crackdown

    SHANGHAI (Reuters) -After more than a decade of explosive growth, China's Singles' Day, the world's biggest online shopping fest, is losing its gloss and bracing for more modest growth in coming years, hurt by a slower economy and tighter regulatory scrutiny. E-commerce giant Alibaba Group Holding Ltd said on Friday its sales - or gross merchandise value - during the 11 day event grew just 8.5%, the slowest rate ever, underscoring the headwinds for China's tech firms. GMV had grown by at least double digits every year since Alibaba founded the festival in 2009 and built it into a global online shopping fest, dwarfing Cyber Monday in the United States.

  • Metals Will Be The Oil Of The Future

    The energy transition is driving the next commodity supercycle, in which certain metals will see huge demand at the expense of crude oil

  • Some Energy Stocks Could Double. Where to Invest Now.

    An industry veteran finds promise in both conventional and alternative energy names. Why he likes Diamondback Energy, Antero Resources, EQT, Cottera Energy, PDC, EOG, Enphase, Enviva, and others.

  • Why Oil’s Hot Streak Could Cool

    Historically, the cure for high oil prices has been high oil prices. Vehicle traffic has mostly stayed on an upward trajectory even as gasoline and diesel prices have risen. Oil and gas prices have kept rising, and are starting to ripple through the economy.

  • NXP forecasts sales growth driven by connected vehicles

    Chipmaker NXP Semiconductors on Thursday said it believes it will hit $15 billion in sales by 2024, with much of the expansion coming from internet-connected electric vehicles. Speaking with Reuters after holding a presentation for investors, NXP Chief Executive Kurt Sievers said the company intended to focus on key areas where more chips are going into cars and where NXP believes it can hold a market position at least twice that of any competitor. One of those areas is radar sensors, which are increasingly being put into cars for safety systems that can automatically brake before a collision.

  • How to Invest in Farmland (Without Buying a Farm)

    Farmland as an alternative investment is a potentially profitable way to diversify your portfolio and minimize risk. Returns on owning farmland, or investing in one of several farming-adjacent sectors, don’t necessarily move with the traditional market. Instead, the land itself … Continue reading → The post How to Invest in Farmland (Without Buying a Farm) appeared first on SmartAsset Blog.

  • Wall Street Warns It Will Cut NYC Workforce in Coming Years

    (Bloomberg) -- Almost a quarter of financial-services firms are planning to reduce their workforces in New York City in the next five years. Most Read from BloombergWhy Hong Kong Is Building Apartments the Size of Parking SpacesDo Prisons Deserve a Second Chance?Farmers Take on ‘Post-Apocalyptic’ Food CrisisCOP26 Protests: Inflatable Cows, Megaphones and a RainbowThat was the highest share of any industry, according to a statement Wednesday from the Partnership for New York City, which surveyed

  • Exclusive-Exxon in talks to build fourth oil production rig for Guyana

    Exxon Mobil is in discussions with Dutch contractor SBM Offshore NV to build a fourth multibillion-dollar production unit to develop its Guyana oil discoveries, two people close to the negotiations said. The talks include the potential for some future platform assembly in Guyana, the people said. Guyana hopes to develop an oil industry infrastructure to boost the economy and job growth.

  • Alibaba's Singles' Day sales growth percentage drops to its lowest in history amid China's crackdown on Big Tech companies

    The world's biggest online shopping event recorded a slower pace of annual growth pace after Alibaba Group Holding swapped the usual razzamatazz of Singles' Day for a more down-to-earth event that stressed sustainability. Alibaba recorded gross merchandise value (GMV) for this year's Singles' Day of 540.3 billion yuan (US$84.5 billion) during the 11-day campaign, marking 8.45 per cent year-on-year growth. This is the first single-digit GMV growth since Alibaba created Singles' Day in 2009. Aliba

  • Tom Barrack Allowed to Resume Real Estate Work While Out on Bail

    (Bloomberg) -- Tom Barrack, the founder of Colony Capital Inc., was allowed to resume his property development business while out on $250 million bail awaiting trial for allegedly acting as an agent of the United Arab Emirates in dealings with U.S. officials. Most Read from BloombergWhy Hong Kong Is Building Apartments the Size of Parking SpacesFarmers Take on ‘Post-Apocalyptic’ Food CrisisDo Prisons Deserve a Second Chance?Greece’s Popular Islands Are Crowded — With PlasticA former top fund-rai

  • Kellogg’s sues its striking cereal-plant workers

    The Kellogg Co. has filed a lawsuit against its local union in Omaha complaining that striking workers are blocking entrances to its cereal plant and intimidating replacement workers as they enter the plant.

  • Housing: The shift to online real estate ‘will ultimately fuel our business,’ Opendoor CFO says

    Opendoor CFO Carrie Wheeler joins Yahoo Finance Live's Zack Guzman and Brian Sozzi to explain how her company was able to grow revenue as Zillow is exiting the home-buying market.

  • GM to launch 10 EVs in S.Korea by 2025; no plans for local manufacture

    General Motors Co will launch 10 electric vehicles (EVs) for the South Korean market by 2025, but has no plans yet to manufacture EVs in the country, Steven Kiefer, the head of GM's international operations said on Friday. The No.1 U.S. automaker, which warned last year that persistent industrial action was preventing further investment in South Korea, builds EVs in the United States and China. Kiefer's visit after a Korean labour union delegation went to Detroit in June had led to speculation in local media that he could announce new EV production plans.

  • Apple Partner Hon Hai’s Profit Tops Estimates on New iPhones

    (Bloomberg) -- Key iPhone assembler Hon Hai Precision Industry Co. posted earnings that topped analysts’ estimates on strong demand for fresh versions of the Apple Inc. handset, but warned that sales will decline this quarter because of persistent chip shortages.Most Read from BloombergWhy Hong Kong Is Building Apartments the Size of Parking SpacesFarmers Take on ‘Post-Apocalyptic’ Food CrisisGreece’s Popular Islands Are Crowded — With PlasticHong Kong's New Museum Tries to Please Art World — an